Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir

L F Verdonck, G C de Gast, A W Dekker, R A de Weger, H J Schuurman, M Rozenberg-Arska

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We studied the effect of cytomegalovirus immunoglobulin alone, or combined with ganciclovir, on the outcome of biopsy proven cytomegalovirus pneumonia after bone marrow transplantation. Treatment with cytomegalovirus immunoglobulin alone had no effect on the cytomegalovirus nor on clinical outcome. The combined treatment of cytomegalovirus immunoglobulin with ganciclovir suppressed the cytomegalovirus but all patients died because of ongoing pulmonary deterioration. These results may suggest that this combined treatment has limited value on the outcome of an established cytomegalovirus pneumonia after marrow transplantation.

Original languageEnglish
Pages (from-to)187-9
Number of pages3
JournalBone Marrow Transplantation
Volume4
Issue number2
Publication statusPublished - 1989

Keywords

  • Acyclovir
  • Adult
  • Antiviral Agents
  • Bone Marrow Transplantation
  • Cytomegalovirus
  • Cytomegalovirus Infections
  • Drug Therapy, Combination
  • Female
  • Ganciclovir
  • Humans
  • Immunization, Passive
  • Immunoglobulins
  • Male
  • Middle Aged
  • Pneumonia, Viral
  • Postoperative Complications

Fingerprint

Dive into the research topics of 'Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir'. Together they form a unique fingerprint.

Cite this